This file product image provided by Meda Pharmaceuticals shows packages of Edluar, a sleep medication that contains the drug zolpidem. (AP Photo/Meda Pharmaceuticals)
WASHINGTON (AP) -- The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.
The agency says new research shows that the widely-used sleeping drugs remain in the blood at levels high enough to interfere with driving, which increases the risk of car accidents.
Regulators are ordering drug manufacturers to cut the dose of the medications in half for women, who process the drug more slowly. The FDA is also recommending that manufacturers use the lower doses for men, though it will not be mandatory.
The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under the brands Ambien, Edluar and Zolpimist.
Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.
Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.
Thursday, May 16 2013 10:59 PM EDT2013-05-17 02:59:24 GMT
How young is too young to wear makeup? You may change your mind after you hear about a shocking new study that says putting on a pretty face can have some ugly side effects.
How young is too young to wear makeup? You may change your mind after you hear about a shocking new study that says putting on a pretty face can have some ugly side effects.
People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.
People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.
An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
KTTV FOX 11 1999 S. Bundy Dr. Los Angeles CA 90025
This file product image provided by Meda Pharmaceuticals shows packages of Edluar, a sleep medication that contains the drug zolpidem. (AP Photo/Meda Pharmaceuticals)
